麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Oct 12 2023

Full Issue

Opvee Nasal Spray For Opioid Overdose Reversals Starts Shipping

Indivior has started shipping a nasal spray version of nalmefene to first responders and pharmacies, four months after the FDA approved it. In L.A. County, libraries are set to offer free naloxone clinics. And in San Antonio, a local pharmacy and pharmacist must pay a $275,000 fine for illegal opioid distribution.

More than four months after the Food and Drug Administration approved the overdose reversal medication Opvee, the manufacturer, Indivior, has started shipping the life-saving drug to first responders and pharmacies. Opvee, a nasal spray version of the drug nalmefene, works by blocking opioid receptors in the brain to quickly reverse the effects of an overdose. The rescue medication is approved for people 12 and older and requires a prescription. (Alltucker, 10/12)

Five Los Angeles County public libraries will host free naloxone clinics starting Wednesday at select locations made possible with a partnership with the County Department of Public Health and California Department of Health Care Services. The free clinics run through Nov. 9. The free doses of naloxone are available and do not require proof of identification, insurance or payment. Those receiving the doses need to complete watching a brief video training of how to administer the medication, and the video will be available on site. The doses are limited to one per customer while supplies last. (10/11)

A federal court has ordered a local pharmacy and pharmacist to pay a $275,000 civil penalty relating to illegal dispensing of opioids and other controlled substances. ... The fine comes following a civil complaint filed in Jan. 2022, stating that prescriptions were being filled in violation of the Controlled Substances Act. The pharmacy also repeatedly ignored "red flags" delegitimizing claims that prescriptions were being used for their intended purpose. (Trejo, 10/11)

Fentanyl is a potent drug that can kill with even the smallest of doses, but what is fentanyl? How is it made, and what's being done to track the people smuggling it into our area? CBS New York takes us inside a Drug Enforcement Administration laboratory for the answers. (McNicholas, 10/11)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优